RO7812653
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 06, 2026
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
(clinicaltrials.gov)
- P1 | N=50 | Recruiting | Sponsor: Hoffmann-La Roche | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
November 20, 2025
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Hoffmann-La Roche
New P1 trial • Alzheimer's Disease • CNS Disorders
1 to 2
Of
2
Go to page
1